Quoin pharmaceuticals announces opening of first clinical site for netherton syndrome clinical study

Three arm, randomized, double-blind, vehicle controlled study will test two doses of qrx003 versus vehicle three arm, randomized, double-blind, vehicle controlled study will test two doses of qrx003 versus vehicle
QNRX Ratings Summary
QNRX Quant Ranking